Siegfried Holding AG

SFZN

Company Profile

  • Business description

    Siegfried is a global contract development and manufacturing organization. It derives its revenue primarily from long-term supply agreements with biotechnology and pharmaceutical customers. Siegfried develops and manufactures active pharmaceutical ingredients, finished dosage forms (tablets, capsules, sterile vials, ampules, cartridges, and ointments), and viral vectors. The company provides these services throughout the entire drug lifecycle, including chemical and analytical development, pilot manufacturing, and commercial-scale manufacturing. Siegfried has a large global footprint with 13 production sites on three continents.

  • Contact

    Untere Bruehlstrasse 4
    ZofingenCH-4800
    CHE

    T: +41 627461111

    E: [email protected]

    https://www.siegfried.ch

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    3,891

Stocks News & Analysis

stocks

Tesla: Shares fall as deliveries come in below consensus

Long-term growth less reliant on auto sales.
stocks

Will Australia’s dwindling fuel supplies impact this share?

Australia’s petrol reserves have dropped from 60 to 35 days.
stocks

US tech stocks sank in Q1 - but the biggest opportunities may be ahead

These 12 undervalued technology stocks look attractive today.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,774.90124.80-1.40%
CAC 407,962.390.000.00%
DAX 4023,168.08130.81-0.56%
Dow JONES (US)46,669.88165.210.36%
FTSE 10010,436.2971.500.69%
HKSE25,116.53177.50-0.70%
NASDAQ21,996.34117.160.54%
Nikkei 22553,413.68290.190.55%
NZX 50 Index12,902.1576.280.59%
S&P 5006,611.8329.140.44%
S&P/ASX 2008,579.50105.50-1.21%
SSE Composite Index3,919.2929.27-0.74%

Market Movers